Ensemble docking to difficult targets in early‐stage drug discovery: Methodology and application to fibroblast growth factor 23

Publisher： John Wiley & Sons Inc

E-ISSN： 1747-0285|91|2|491-504

ISSN： 1747-0277

Source： CHEMICAL BIOLOGY & DRUG DESIGN (ELECTRONIC), Vol.91, Iss.2, 2018-02, pp. : 491-504

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fibroblast Growth Factor-23—A Potential Uremic Toxin

By Kuczera Piotr   Adamczak Marcin   Wiecek Andrzej  

Toxins, Vol. 8, Iss. 12, 2016-12 ,pp. : 369-369

MDPI

Access to resources Recommend Favorite

Hepatoma-Derived Growth Factor Upregulation Is Correlated with Prognostic Factors of Early-Stage Cervical Adenocarcinoma

By Tsai Ching-Chou   Huang Shun-Chen   Tai Ming Hong   Chang Chien Chan-Chao   Huang Chao-Cheng   Hsu Yi-Chiang  

International Journal of Molecular Sciences, Vol. 15, Iss. 11, 2014-11 ,pp. : 21492-21504

MDPI

Access to resources Recommend Favorite

Experimental Myocardial Infarction Upregulates Circulating Fibroblast Growth Factor‐23

By  

JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 884-0431, Iss. 10, 2015-10 ,pp. : 1831-1839

John Wiley & Sons Inc

Access to resources Recommend Favorite

Growth Differentiation Factor-9 Promotes Fibroblast Proliferation and Migration in Keloids through the Smad2/3 Pathway

By  

Cellular Physiology and Biochemistry, Vol. 40, Iss. 1-2, 2016-11 ,pp. : 207-218

Karger

Access to resources Recommend Favorite

The Fibroblast Growth Factor signaling pathway

By  

WILEY INTERDISCIPLINARY REVIEWS: DEVELOPMENTAL BIOLOGY (ELECTRONIC), Vol. 4, Iss. 3, 2015-05 ,pp. : 215-266

John Wiley & Sons Inc

Access to resources Recommend Favorite